아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

rowex ltd - perindopril tert-butylamine - tablet - 2 milligram(s) - ace inhibitors, plain; perindopril

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

rowex ltd - perindopril tert-butylamine - tablet - 4 milligram(s) - ace inhibitors, plain; perindopril

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

rowex ltd - perindopril tert-butylamine - tablet - 8 milligram(s) - ace inhibitors, plain; perindopril

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

rowex ltd - perindopril tert-butylamine; indapamide - tablet - 4 mg/1.25 milligram(s) - ace inhibitors and diuretics; perindopril and diuretics

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

bayer limited - ethinylestradiol (as betadex-clathrate) drospirenone - film coated tablet - 0.020+3.00 milligram

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

bayer limited - ethinylestradiol; drospirenone - film-coated tablet - 0.02 mg/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

싱가포르 - 영어 - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - flupentixol dihydrochloride eqv flupentixol; melitracen hydrochloride eqv melitracen - tablet, film coated - 0.5 mg - flupentixol dihydrochloride eqv flupentixol 0.5 mg; melitracen hydrochloride eqv melitracen 10 mg

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, uncoated - excipient ingredients: magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; purified talc; microcrystalline cellulose - yvette is indicated for use as: - an oral contraceptive. - treatment of moderate acne vulgaris in women who seek oral contraception - treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yvette for pmdd was not assessed beyond 3 cycles. yvette has not been evaluated for treatment of pms (premenstrual syndrome), see clinical trials.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, uncoated - excipient ingredients: magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; purified talc; microcrystalline cellulose - leah is indicated for use as: - an oral contraceptive. - treatment of moderate acne vulgaris in women who seek oral contraception - treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of leah for pmdd was not assessed beyond 3 cycles. leah has not been evaluated for treatment of pms (premenstrual syndrome), see clinical trials.

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - drospirenone; ethinylestradiol - oral tablet - 3mg ; 20microgram